UC-San Francisco: Could Two Drugs Be Better Than One for Treating Prostate Cancer?
January 24, 2024
January 24, 2024
SAN FRANCISCO, California, Jan. 24 (TNSres) -- The University of California San Francisco campus issued the following news release:
* * *
UCSF-led clinical trial shows improved benefit of combination drug therapy without worse side effects.
* * *
Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, phase 3 clinical trial led by . . .
* * *
UCSF-led clinical trial shows improved benefit of combination drug therapy without worse side effects.
* * *
Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, phase 3 clinical trial led by . . .